SEC Filings

OTCQXZCOR
FormDescriptionDateFormat
SC 13G/AAmendment to a previously filed SC 13GDec 11, 2017View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerNov 2, 2017Download DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECOct 26, 2017View HTMLDownload DOCDownload PDFDownload XLS
UPLOADCorrespondence from the SEC to the FilerSep 28, 2017Download DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJul 17, 2017View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderMay 22, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GMay 10, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GMar 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 8, 2017View HTMLDownload DOCDownload PDFDownload XLS

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.